Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial

27 May 2025 07:00 CEST

Bergen, Norway, 27 May 2025 -- Lifecare ASA (LIFE), a medtech company
developing next-generation Continuous Glucose Monitoring (CGM) technology, is
pleased to announce that Professor Simon Nitter Dankel has been appointed as
Principal Investigator for its upcoming clinical trial.

Prof. Dankel is a leading expert in metabolic diseases and nutritional
biochemistry, with an impressive track record of high-impact research and
leadership in clinical trials. He currently heads the Research Unit for Health
Surveys (RUHS) at the University of Bergen, which will host the first trial
site.

RUHS brings extensive experience in executing clinical and decentralized
trials and offers state-of-the-art infrastructure including a metabolic
kitchen, biobank collaboration, and GDPR-compliant digital systems for
participant management. This partnership sets the stage for robust,
high-quality data collection and world-class regulatory standards.

This appointment follows Lifecare's recent filing for regulatory approval to
launch the clinical trial of its innovative CGM implant, marking another key
milestone toward CE-marking and commercial launch.

"Engaging Prof. Dankel and RUHS is a strategic move that highlights our
commitment to scientific excellence and clinical rigor," said Joacim Holter,
CEO of Lifecare ASA. "Their expertise will be instrumental as we accelerate
efforts to bring our transformative technology to people living with
diabetes."

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is suitable for identifying and monitoring the occurrence of a wide
range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

More information:
Access the news on Oslo Bors NewsWeb site

647562_Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial.pdf